# OnCo record andrew-wei (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/andrew-wei/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "andrew-wei" ;
  schema:name "Andrew H. Wei"@en ;
  schema:description "Australian haematologist who led VIALE-C and QUAZAR AML-001, advancing venetoclax and oral azacitidine maintenance in AML."@en ;
  schema:url <https://onco.cc/people/andrew-wei/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Wei%20AH%5BAuthor%5D%20venetoclax%20azacitidine> ;
  onco:tag "aml", "venetoclax", "australia" ;
  schema:jobTitle "Consultant Haematologist, Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Professor, University of Melbourne" ;
  schema:sameAs <https://orcid.org/0000-0002-7514-3298> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/bcl2/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/> ;
  onco:institutions <https://onco.cc/institutions/peter-mac/>, <https://onco.cc/institutions/wehi/> ;
  onco:journals <https://onco.cc/journals/blood/> ;
  schema:affiliation <https://onco.cc/institutions/peter-mac/> .